Medicine and Healthcare | Media Room | Newswire

5 Benefits of Remote Patient Monitoring (RPM) for Patients and Healthcare Providers

Tue, 03 Nov 2026 17:40:00 +0000

Discover five RPM benefits, including earlier intervention, better chronic disease management, patient engagement, and improved care coordination.

Suncoast Skin Solutions Surpasses 48,000 Five-Star Patient Reviews

Mon, 02 Nov 2026 17:45:00 +0000

Florida dermatology practice reaches milestone across more than 40 locations

CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)

Mon, 02 Nov 2026 14:00:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

CORRECTION: Dr. Feliciano Serrano Connects Kidney Care with Clear Communication for Los Angeles Families

Fri, 30 Oct 2026 23:00:00 +0000

This release corrects and replaces the previous release disseminated Thursday, 29 October 2026 at 07:08 PM ET with an incorrect image.

Please see the corrected release below.

A closer look at bilingual patient education, specialist preparation, research, and the community background of a Huntington Park physician.

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

Fri, 30 Oct 2026 14:30:00 +0000

Surmodics Launches MetalPro(TM) Direct-to-Metal Hydrophilic Coatings for Medical Devices

Fri, 30 Oct 2026 13:37:00 +0000

High-performance hydrophilic coatings bond directly to metal surfaces without primers or tie-coats, simplifying manufacturing and expanding design flexibility.

MiVu Mucosal Integrity Testing System Marks 25,000 Procedures Performed

Thu, 29 Oct 2026 16:00:00 +0000

A procedural milestone reflecting the growing adoption of mucosal integrity testing for aiding physicians in the diagnosis of GERD, EoE, and Non-GERD during routine endoscopy.

Fortune Media and Great Place To Work Name CareChoice to 2026 Best Workplaces for Women List, Ranking No. 23

Wed, 28 Oct 2026 18:00:00 +0000

Recognition based on more than 640,000 survey responses from women honors CareChoice for a culture where employees feel valued, supported, and empowered

AAMA Installs Sherry Bogar, CMA (AAMA), as 2026-2027 AAMA President

Wed, 28 Oct 2026 16:30:00 +0000

Medical Component Specialists Appoints Pedro Moreira to Multisite Quality Manager III as Costa Rica Facility Begins Operation

Tue, 27 Oct 2026 20:25:00 +0000

Medical Component Specialists (MCS), a leading provider of medical components, proudly announces the appointment of Pedro Moreira as Global Multisite Quality Manager III.

As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides

Tue, 27 Oct 2026 13:15:00 +0000

Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder

Wed, 21 Oct 2026 13:00:00 +0000

Mutation of the GUCY2C gene is the third IF-related congenital enteropathy, in addition to microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF), for which crofelemer has demonstrated benefit in reducing parenteral support needs in pediatric patients

Company plans to file NDA for crofelemer for MVID in mid-2027 to obtain FDA approval

Chris Belford to Depart as Co-Chairman of Sinceri Senior Living

Tue, 20 Oct 2026 17:20:00 +0000

NanoViricides' Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials

Tue, 20 Oct 2026 12:45:00 +0000

The Spreading Ebola Epidemic as well as Mpox Endemic in Africa Disproportionately Impact Children; The Measles Outbreaks Primarily Impact Children

Lobe Sciences Appoints Tracy L. Goeken, M.D., as Chief Medical Officer

Tue, 20 Oct 2026 12:30:00 +0000

Physician executive brings clinical development and regulatory experience in generalized anxiety disorder and sickle cell disease

Company also engages Independent Trading Group (ITG) to provide market-making services

TriageLogic's MedMessage Automate Addresses the Top Digital Priority in BDO's 2026 Healthcare Survey

Tue, 20 Oct 2026 12:00:00 +0000

Provider executives ranked patient self-service and engagement tools as their #1 digital priority. MedMessage Automate brings that digital front door to the phone lines of physician practices and health system clinics while keeping front-desk staff in control.

Dr. Vinson Eugene Allen Concerned About Rising Breast Cancer Rates in Los Angeles

Thu, 15 Oct 2026 23:45:00 +0000

Dusk to Dawn Urgent Care Plans to Service Uninsured Patients

Vogenx Initiates Phase 2b EMERGE Study of Mizagliflozin for Post-Bariatric Hypoglycemia

Thu, 15 Oct 2026 20:35:00 +0000

Randomized, double-blind, placebo-controlled trial will evaluate two doses of the first-in-class, minimally absorbed SGLT1 inhibitor in patients with recurrent hypoglycemia following bariatric surgery

Jaguar Health Provides Update Regarding Special Stock Dividend

Wed, 14 Oct 2026 20:15:00 +0000

Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives

Jaguar's rare disease intestinal failure development program for microvillus inclusion disease (MVID) and short bowel syndrome for crofelemer powder for oral solution is expected to continue to provide clinical milestones, including a planned New Drug Application (NDA) filing for crofelemer for MVID in mid-2027

Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer

Wed, 14 Oct 2026 13:00:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for SBS-IF and microvillus inclusion disease (MVID) for crofelemer powder for oral solution, targeting a mid-2027 NDA filing for MVID

Lobe Sciences Appoints Annette Grimaldi, Former Head of Life Sciences Investment Banking at BMO Capital Markets, to Board of Directors

Wed, 14 Oct 2026 12:00:00 +0000

Executive with three decades of life sciences financing and M&A experience joins the board as Lobe advances L-130 in anxiety and cluster headache and S-100 in sickle cell disease

Medical Components Costa Rica is Launching

Tue, 13 Oct 2026 16:20:00 +0000

After three years of development, Medical Component Specialists’ (MCS) Costa Rican grinding facility has opened.

QuickMD Surpasses 2 Million Patient Visits

Tue, 13 Oct 2026 13:30:00 +0000

More than 500,000 visits in 2026 so far as the company expands into new states and service lines and adds more than 80 clinicians in six months

Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

Tue, 13 Oct 2026 13:00:00 +0000

Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives

Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

Tue, 13 Oct 2026 12:45:00 +0000

Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness

Tue, 13 Oct 2026 10:30:00 +0000

Company Achieves Toray Contractual Milestone with Establishment of Manufacturing Site

Dr. Vinson Eugene Allen Sounds the Alarm on Rising Breast Cancer Rates Among Los Angeles Women

Mon, 12 Oct 2026 18:45:00 +0000

Dusk to Dawn Urgent Care is widening breast‑screening services for uninsured communities

Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC(R) at 8th ICRS Summit in Portugal

Mon, 12 Oct 2026 13:00:00 +0000

Engagement with leading orthopedic surgeons and cartilage repair specialists highlights growing awareness of GelrinC's off-the-shelf regenerative technology

GelrinC is CE Mark approved in Europe, where Regentis is expanding its network of Centers of Excellence to support surgeon training and commercialization efforts

European clinical sites also support the Company's ongoing U.S. FDA pivotal Phase III trial

Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City

Fri, 09 Oct 2026 20:05:00 +0000

RGNT to present at ThinkEquity Conference Oct. 15, 2026 in New York. Learn about GelrinC knee cartilage implant and one-on-one investor meetings

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer

Fri, 09 Oct 2026 12:00:00 +0000

Thirty-year biopharmaceutical commercial leader transitions from the Board of Directors to Chief Commercial Officer

Appointment strengthens corporate strategy, business development and commercial readiness as the Company advances mizagliflozin following its August 2026 initial public offering

Surmodics Launches IOL Cartridge Coating Automation Center in Horsham

Wed, 07 Oct 2026 19:30:00 +0000

New center combines advanced hydrophilic coating technology, IOL cartridge application expertise and automated processing to support scalable ophthalmic device manufacturing

Vituity Cares Brings Music and Purpose to Nashville With Benefit Concert at Cannery Hall

Wed, 07 Oct 2026 13:00:00 +0000

Demola, Elijah Scott, Coey Redd, DJ Delano, Trew the Star, and Jeffrey ‘Sax' Stevenson come together for a special evening of live music supporting Vituity Cares' mission to expand access to care and strengthen communities

Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi

Tue, 06 Oct 2026 13:00:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

A recent Rareatives article shares the story of a young child living with MVID, highlighting the importance of family perspectives, supportive communication, and collaboration with clinicians in addressing rare intestinal diseases

Bluejay Diagnostics Announces SYMON-II Clinical Dataset Details Supporting Evaluation of Mortality Risk in Sepsis and Septic Shock

Tue, 06 Oct 2026 10:30:00 +0000

SYMON-II Clinical Validation Dataset Represents a Key Milestone as Bluejay Advances the Symphony™ IL-6 Test Toward Regulatory Submission

The Assistance Fund Opens New Program for Glycogen Storage Disorder Type 1A

Mon, 05 Oct 2026 16:00:00 +0000

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Glycogen Storage Disorder Type 1A

The Assistance Fund Opens New Program for MPS IIIA-Sanfilippo A Syndrome

Mon, 05 Oct 2026 16:00:00 +0000

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With MPS IIIA-Sanfilippo A Syndrome

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives

Mon, 05 Oct 2026 12:45:00 +0000

Jaguar Health Announces a Special Stock Dividend

Sat, 03 Oct 2026 00:35:00 +0000

Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives

California Care Recovery Launches Quarterly Scholarship Covering Full Cost of Addiction Treatment - Including Travel - at No Cost

Thu, 01 Oct 2026 16:00:00 +0000

The Care Forward Scholarship awards up to $60,000 in treatment every quarter to one person in need, at no cost

Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities

Thu, 01 Oct 2026 12:00:00 +0000

Acquisition adds proven PzF^™ thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility

MD Clarity Unveils Major Expansion of RevFind with Agentic AI to Optimize the Revenue of Provider Organizations

Wed, 30 Sep 2026 15:00:00 +0000

MD Clarity expands RevFind product’s agentic AI capabilities to detect underpayments and denials, uncover root causes, and prioritize recovery opportunities

Chicken Soup for the Soul Co-Author Publishes Ayahuasca For the Soul

Tue, 29 Sep 2026 17:10:00 +0000

79 true stories of hope, healing and breakthrough from veterans, celebrities, CEOs and everyday seekers who journeyed with plant medicine

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

Tue, 29 Sep 2026 12:45:00 +0000

Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting

Tue, 29 Sep 2026 08:30:00 +0000

Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and SBS-IF for crofelemer powder for oral solution, targeting an NDA filing for MVID mid-2027

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

Mon, 28 Sep 2026 12:45:00 +0000

Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants

Fri, 25 Sep 2026 18:20:00 +0000

Engineered 20-nanometer surface architecture on Innovasis' HA-coated titanium implants was reviewed and cleared under the FDA's Nanotechnology Guidance, confirming nanoscale surface features with increased hydrophilicity compared to micro-rough titanium surfaces.

NGD Infection Prevention Announces Launch of Transmission Detection at Sheba Medical Center in Israel

Thu, 24 Sep 2026 22:15:00 +0000

NGD's automated whole genome sequencing and bioinformatic result generation is accelerating Sheba's ability to detect the spread of drug-resistant bacterial infection

Wellness Recovery Center Opens New Residential Eating Disorder Treatment Center in Orange County

Thu, 24 Sep 2026 19:00:00 +0000

The Tustin Ranch-area facility offers 24/7 inpatient care in a residential setting for adults 18 and older living with eating disorders and co-occurring mental health conditions

As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern "Heady" Burnout

Thu, 24 Sep 2026 13:00:00 +0000

Addressing the growing demand for non-psychedelic micro-rituals, Sacred Connection bridges ancestral Amazonian preparations with North America's microdosing and flow-state communities.

Power Couple Dr. Vinson Eugene Allen and Dr. Connie Yu Allen Honored by the Los Angeles Business Journal

Wed, 23 Sep 2026 20:40:00 +0000

Healthcare leaders recognized for advancing accessible care and strengthening community health programs